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Abstract
Atherosclerosis causes significant morbidity and mortality. Carotid intima-media thickness (CIMT) predicts
future cardiovascular and ischaemic stroke incidence. CIMT, a measure of atherosclerotic disease, can be
reliably determined in vivo by carotid ultrasound. In this review, we determined that CIMT is associated with
traditional cardiovascular risk factors such as age, sex, race, smoking, alcohol consumption, habitual endurance
exercise, blood pressure, dyslipidemia, dietary patterns, risk-lowering drug therapy, glycemia, hyperuricemia,
obesity-related anthropometric parameters, obesity and obesity-related diseases. We also found that CIMT is
associated with novel risk factors, including heredity, certain genotypic indices, anthropometric cardiovascular
parameters, rheumatoid arthritis, immunological diseases, inflammatory cytokines, lipid peroxidation,
anthropometric hemocyte parameters, infectious diseases, vitamin D, matrix metalloproteinases, and other
novel factors and diseases. However, the conclusions are inconsonant; the underlying causes of these
associations remain to be further explored.
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Background
Atherosclerosis is an important pathologic cause of car-
diovascular (CV) and cerebrovascular diseases. Add-
itionally, CV and cerebrovascular diseases are the
leading causes of mortality in humans and can have sig-
nificant impacts on morbidity. Therefore, the early pre-
vention of CV and cerebrovascular diseases has become
a focus of current research. Preclinical atherosclerosis
has been related to higher coronary heart disease and
stroke rates. Studies have demonstrated that carotid
ultrasonography [1] is more sensitive than the coronary
artery calcification score (CACS) for the detection of
subclinical atherosclerosis. Hence, carotid intima-media
thickness (CIMT) ultrasonography may represent an ac-
cessible and reliable method to detect subclinical athero-
sclerosis [2]. CIMT is significantly increased in patients
with existing plaques [3], is a marker of subclinical organ
damage and is an independent predictor of CV and cere-
brovascular events. Several studies have reported that
associations exist between CIMT and established risk
factors. Thus far, the current concepts of the risk factors
of CIMT in the existing literature are not unified. We
combined the existing reports to summarize the risk fac-
tors of CIMT, including traditional risk factors that have
been recognized, such as age, sex, smoking, alcohol con-
sumption, blood pressure (BP), blood fat, blood sugar,
lifestyle habits and others; however, the traditional risk
factors do not explain all of the risks. A recent study re-
vealed that >60Â % of CIMT cases were not explained
by demographic and traditional CV risk factors, which
highlights the need to study novel risk factors [4], which
likely represent additional risk factors for carotid athero-
sclerosis. These novel risk factors refer to recently
researched and not yet widely recognized risk factors,
such as lifestyle, job pressure, certain diseases, genetic
risk factors for certain diseases, and novel environmen-
tal, physiologic and pathologic parameters. Therefore, to
further understand the factors that influence CIMT asso-
ciated with traditional CV risk factors and novel risk fac-
tors, we have reviewed the relevant literature from
PubMed by searching the keywords: "ultrasound" AND
"carotid intima-media thickness" AND "clinical research"
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AND "traditional cardiovascular risk factors" OR "novel
risk factors". Identifying novel risk factors associated
with CIMT will be helpful for the prevention and treat-
ment of early atherosclerosis.
The associations between CIMT and traditional CV
risk factors
The associations between CIMT and age, sex, race,
smoking, alcohol consumption and habitual endurance
exercise
Age, sex, race, smoking and alcohol consumption play
important roles in atherosclerosis. CIMT may be a valu-
able marker for CV risk in adults aged <45Â years who
are not yet eligible for standard CV risk screening [5].
Gestational age was not found to affect CIMT [6], and
age-related increases in CIMT correlated with a decline
in cardiac diastolic function only in women [7]. CIMT
was similar between healthy South Asian and European
men [8]. Although males exhibited a significantly greater
CIMT than females, the difference failed to reach statis-
tical significance after adjusting for carotid diameter [9].
However, sex differences in the associations between
childhood and adulthood risk factors and subclinical
atherosclerosis were found [10]. Additionally, CIMT was
positively associated with smoking [11] and alcohol con-
sumption in men [12]. However, an opposite finding
showed that alcohol consumption might also be benefi-
cial for CIMT in men and that the effect of alcohol on
CIMT might be mediated by lipid factors [13]. Habitual
endurance exercises, particularly aerobic exercise, are
important measures of atherosclerosis prevention. Previ-
ous studies have revealed that 8Â weeks [14] or 6
months [15] of aerobic exercise training might signifi-
cantly improve the vascular structure and function in
African Americans. The weight-adjusted maximal oxy-
gen uptake capacity inversely correlates with CIMT [16].
However, although habitual endurance exercise might
improve CV risk profiles, it does not reduce the magni-
tude of carotid atherosclerosis associated with age and
CV risk factors [17]. Hence, determining the effects of
different exercises on CIMT requires further studies.
The associations between CIMT and BP
High BP has been recognized as an important risk factor
for CV and cerebrovascular diseases. However, the asso-
ciations between CIMT and different types of abnormal
BP in different populations remain unknown. High BP is
a major determinant of CIMT [18]. Systolic BP [19-21],
diastolic BP (DBP) [10, 22], higher pulse pressure (PP)
[6, 21], daytime BP [23], persistently elevated BP from
childhood to adulthood [24], within-visit DBP variability
in the normotensive population [25] and systolic BP
variability (SBPV) [26] were also found to be positively
associated with CIMT. SBP [27] appears to be a main
pathological mechanism that indirectly affects CIMT
through the hemodynamic pathway. This risk was
reduced if BP that was elevated during childhood was
resolved by adulthood [24]. Moreover, the correlation
between BP variability (BPV) and left common carotid
artery-intima-media thickness/number of plaques is
stronger than right common carotid artery-intima-media
thickness/number of plaques [26]. The increase in CIMT
in Congolese hypertensive subjects was identified as a
marker of arterial remodeling associated with a long his-
tory of uncontrolled hypertension rather than of early
atherosclerosis [28]. In a sample of hypertensive African
men, CIMT was negatively associated with glutathione
(GSH) levels [29], suggesting that CIMT might contribute
to the attenuation of GSH levels in the development of
subclinical atherosclerosis. In summary, all types of hyper-
tension are major causes of preclinical atherosclerosis.
Thus, to achieve prevention of early atherosclerosis,
proper measures should be taken to control hypertension.
The associations between CIMT and dyslipidemia, dietary
patterns and risk-lowering drug therapy
Healthy and unhealthy lifestyle changes during young
adulthood are associated with decreased and increased
risks, respectively, for subclinical atherosclerosis in mid-
dle age [30]. Dyslipidemia is an important factor for ath-
erosclerosis that has been shown to be associated with
CIMT [18]. Regression analysis demonstrated that the
mean and maximum CIMT (CIMT[max]) are independ-
ently influenced by age, blood creatinine levels and non-
high density lipoprotein (HDL) cholesterol levels [22]. In
particular, patients with familial hypercholesterolemia
(FH) are at increased risk of premature CV disease.
Hypercholesterolemic children [31] and patients with
FH [32] exhibited significantly higher CIMT. Results of
CIMT meta-analysis strengthen the evidence of early
atherosclerotic development in children with FH. Circu-
lating low-density lipoprotein (LDL-C) concentrations
were associated with CIMT [33, 34], and high levels of
oxidized LDL (OxLDL) were significantly associated with
progression and increased levels of CIMT [35-37]. Low
levels of HDL cholesterol or relative levels of the HDL
3b subclasses and changes in the proportion of small
HDL particles were significantly associated with an
increased in CIMT [20, 38] and with the presence of
carotid plaques [39]. Furthermore, among women,
IMT(max) was significantly negative correlated to HDL
cholesterol [40]. In the statin group, HDL cholesterol
levels were associated with CIMT; in the combined ther-
apy group, HDL cholesterol levels were the only signifi-
cant correlate of CIMT [41]. Apoliproproteins are also
important risk factors for atherosclerosis. Among them,
apolipoprotein B(apoB) [33] and ApoB/ApoA1 [42] were
significantly positively associated with CIMT, and the
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absence or very low levels of erythrocyte-bound apoB
was associated with clinical and subclinical atheroscler-
osis [43]. In contrast, other studies revealed that ApoE
genotypes and CIMT were not associated [44] and that
ApoA1 has an inverse association with CIMT [42].
Therefore, whether changes in dietary patterns affect the
risk of early atherosclerosis remains under debate. One
study did not find an association between dietary pat-
terns and IMT or plaques [45], and high versus low pro-
tein intake in infancy did not influence CIMT at
5Â years [44]. However, several studies have demon-
strated that a Mediterranean diet has a protective effect
on the CV system because lower adherence to a Medi-
terranean diet was shown to increase the risk of subclin-
ical atherosclerosis [46]. Additionally, 12Â months of
Mediterranean diet intervention caused a significant re-
duction in CIMT [31]. Interventions to lower LDL chol-
esterol from the suboptimal to the optimal range were
shown to have potentially significant benefits to fire-
fighters [34]. Atorvastatin [47], rosuvastatin [48] and
fuvastatin [49] treatments slowed or reduced the pro-
gression of CIMT; intensive lipid lowering and antihy-
pertensive therapy along with a reduction in central
fat [50] may be considered a mandatory treatment
strategy in young patients with FH to prevent athero-
sclerosis and to increase arterial stiffness. In men with
CHD and high levels of Lp(a), atorvastatin use [51]
results in an average 0.06Â mm decrease in CIMT
over 6Â months. Adequate statin treatment [52]
might delay carotid atherosclerosis in FH independent
of Lp(a) levels. Hence, CIMT was associated with dys-
lipidemia and dysapoliproprotein but was not associ-
ated with protein intake. Therefore, intensive lipid-
lowering therapy might be used to reduce the pro-
gression of CIMT in high-risk patients.
The associations between CIMT and glycemia and
hyperuricemia
Glycemia and hyperuricemia are also important risk fac-
tors for atherosclerosis-related CV and cerebrovascular
diseases. The glycemic status is associated with all
grades of carotid atherosclerosis, from early signs, as
demonstrated by the IMT; to intermediate degrees, as
demonstrated by the presence of carotid plaques; to
advance atherosclerosis, as established by the presence
of carotid stenosis [53]. Glycemia, including type 2 dia-
betes mellitus (T2DM) and impaired fasting glucose
(IFG) [54], is a major independent determinant of CIMT
in hyperglycemic patients. Insulin levels, the HOMA-IR
index, total IGF-1 levels [55] and increased insulin
resistance [56] are positively associated with CIMT; sim-
ultaneously, insulin resistance in obese adolescents [57]
can impair changes in CIMT and can lead to the early
development of atherosclerosis. Lower hemoglobin A1c
levels [58] were also identified as a significant risk factor
for carotid atherosclerosis in rural community-dwelling
elderly Japanese men. Low levels of plasma obestatin
might be related to early arteriosclerosis in patients with
T2DM via increasing CIMT [59], considering that the el-
evated plasma obestatin levels might protect T2DM pa-
tients against carotid atherosclerosis to some extent.
Despite reproducing the association between CIMT level
and vascular risk in subjects with diabetes, no associ-
ation between CIMT change and vascular risk was found
[60]. However, in patients with T2DM, a 6-month inten-
sive lifestyle modification intervention might result in
improved glycemic control and decreased progression of
CIMT [61]. Additionally, hyperuricemia is an independ-
ent risk factor for CV and cerebrovascular diseases.
Hyperuricemia was inversely associated with subclinical
carotid atherosclerosis in men; however, hyperuricemia-
related renal impairment was a significant marker of
subclinical carotid atherosclerosis in both men and
women [62]. Therefore, a timely intervention for gly-
cemia and hyperuricemia may slow the occurrence of
early arteriosclerosis. This timeliness should be a pri-
mary focus for clinicians.
The associations between CIMT, obesity-related
anthropometric parameters, obesity and
obesity-related diseases
Obesity-related anthropometric parameters, obesity and
obesity-related diseases, including nonalcoholic fatty
liver disease (NAFLD), alcoholic fatty liver disease
(AFLD) and polycystic ovary syndrome (PCOS), have
been reported to be associated with increased CV and
cerebrovascular risks. However, the conclusions of the
studies in the literature are inconsistent.
The associations between CIMT and obesity-related
anthropometric parameters
Numerous obesity-related anthropometric parameters
are used for evaluating the associations between obesity
and atherosclerosis-related diseases. Studies have shown
that higher CIMT correlated with obesity-related an-
thropometric parameters, including body mass index
(BMI) [18, 63], waist circumference [18], waist-to-hip
ratio (WHR) [39, 51] and WHtT [39]. Additionally, the
associations between CIMT and fat distribution remain
unknown. Visceral adipose tissue (VAT) thickness [64,
65], but not subcutaneous fat thickness [65], was associ-
ated with IMT in men and patients requiring peritoneal
dialysis. Increased epicardial fat volume [66, 67] and
peri-aortic root fat (PARF) [68] were shown to be inde-
pendent risk factors of increased CIMT. However, a
contradictory study [69] suggested that CIMT lacked a
relationship with visceral obesity. Thus, prospective
studies are needed to further determine the associations
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between CIMT and visceral obesity. Additionally, recent
research has demonstrated that the mean CIMT varied
across obesity phenotypes [59]; a higher CIMT value and
positive associations with carotid plaque and carotid ath-
erosclerosis were observed in only the metabolically ab-
normal obese subtype [70]. These contradictory findings
[71] suggested that obesity does not affect vascular pa-
rameters related to early atherosclerosis, including
CIMT in women with minor CV risk factors. Further re-
search studies are warranted to identify the correlation
between different fat distributions and CIMT.
The associations between CIMT and obese and
obesity-related diseases
Recent studies have suggested that overweight, obese
and obesity-related diseases, including NAFLD, AFLD
and PCOS, are associated with CIMT. Overweight, obese
and morbidly obese patients exhibit similar CIMT and
small artery reactivity index values [72]. Patients with
NAFLD [35, 73-75] and AFLD [35, 76] had significantly
increased CIMT, and the association between NAFLD
and subclinical atherosclerosis was independent of trad-
itional risk factors [75]. ALD may also promote the pre-
mature increase in CIMT [76] via mechanisms that
might include insulin resistance [77] and abnormal liver
function, including ALT [78, 79] and GGT [78], in
patients with NAFLD and NASH. Age and metabolic
factors are also associated with CIM thickening in
patients with ALD. PCOS is a common gynecological
disease in women, and independent of obesity, patients
with PCOS may present with increased CIMT as a direct
result of androgen excess [80], suggesting that hyperan-
drogenism might increase atherosclerosis and CV risks.
However, the findings of another study [71] did not sup-
port the above conclusions. Therefore, the precise rela-
tionships between CIMT and NAFLD, AFLD, and PCOS
require further study.
The associations between CIMT and novel risk
factors
The associations between CIMT and heredity and certain
genotypic indices
Heredity and genetics play important roles in athero-
sclerosis. However, whether CIMT is associated with
heredity and certain genotypic indices remains un-
known. One study suggested that a different set of genes
influences variation in CIMT and waist circumference
[81]. Certain genetic loci that are determinants of hu-
man lung function also influence CIMT and CAD sus-
ceptibility [82]. The strongest association was reported
between the rate of telomere shortening in adults be-
tween 53 and 60-64 years and CIMT in adults 60 to
64Â years of age [83]. However, the chromosome 9p21
locus does not influence CAD risk through a mechanism
that also affects CIMT or that induces early changes in
flow-mediated dilatation (FMD) [84]. The haptoglobin
(Hp) 2-2 genotype is a significant predictor of premature
atherosclerosis and is associated with increased CIMT in
children with beta-thalassemia major [85]. Single-
nucleotide polymorphisms (SNPs) in 7-dehydrocholesterol
reductase/NAD synthetase-1 interacted with type 2 dia-
betes to significantly influence the progression of CIMT in-
dependent of 25(OH)D levels and established risk factors
[86]. However, no significant associations were identified
between the genotype at any of the SNPs and CIMT in 846
individuals with acceptable measurements [87]. Addition-
ally, humans with the Osteopontin âˆ’66 TT genotype,
particularly those without MetS, exhibit thicker CIM [88].
Hence, the associations between CIMT and heredity
require further exploration to search for better etiological
treatment.
The associations between CIMT and anthropometric CV
parameters
Recent studies have reported that certain cardiac- and
artery-related changes may be associated with CIMT.
These changes are important complications of T2DM.
Studies have revealed that increased CIMT is associated
with a high occurrence of cardiac autonomic neuropathy
(CAN) [89], the level of coronary artery calcification
(CAC) [90] and the coronary SYNTAX score [91]. How-
ever, coronary artery disease (CAD) variants were not
found to be associated with CIMT and did not appear to
mediate the risk of atherothrombosis through known
risk factors [90]. Additionally, impaired FMD under
various statuses and diseases might led to thicker
CIM [78, 92, 93]. Their exact mechanism remains un-
known and needs to be further studied.
The associations between CIMT and rheumatoid arthritis
(RA) and immunological diseases
Growing evidence has demonstrated that patients with
RA, Behcet disease (BD), systemic lupus erythematosus
(SLE), primary SjÃ¶gren syndrome, and psoriatic arth-
ritis (PsA) have a higher risk for atherosclerosis and are
associated with enhanced CV risk and subclinical vascu-
lar disease. RA is associated with an elevated risk of car-
diovascular disease (CVD) [94] events and subclinical
atherosclerosis [94, 95]. However, a contradictory study
reported that RA does not result in CIM thickening
[45]. Recent quantities clinical observations have con-
firmed that RA is associated with increased CIMT
[96-99]. The mechanisms of RA-related CIM thickening
included increased levels of Ox-LDL) [100, 101], vWF ac-
tivity [102], serum mannose-binding lectin [103], and
PWV [104] as well as increased levels of inflammation
markers [99, 102] such as IL-17 [105], and CRP [106] and
lower levels of Î²-carotene [101], vitamin D, CD34+ cells
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[100, 104] and NO [101]. Psoriasis is associated with in-
creased mean CIMT [107] and may increase the burden
of subclinical atherosclerosis [107, 106]. More severe sub-
clinical atherosclerosis was observed in patients with PsA
[108] compared with patients with cutaneous psoriasis
without arthritis (PsC). The causes of atherosclerosis in
PsA include markers of accelerated atherosclerosis such as
ox-LDLs and NO [101] as well as endothelial dysfunction
[106], PsA disease duration, more severe skin disease and
increased inflammatory markers; however, atherosclerosis
in PsA was not associated with traditional CV risk factors
[108]. Furthermore, increased CIMT was associated with
juvenile idiopathic arthritis [109], systemic lupus erythe-
matosus [110], and BD [111]. Their mechanisms involved
elevated myeloperoxidase levels in juvenile idiopathic
arthritis [109], circulating levels of OxLDL and the % of
LDL in systemic lupus erythematosus [110] and impaired
FMD in BD [111]. Multivariate model analysis [112]
showed that primary SjÃ¶gren syndrome (SS) might be an
independent risk factor for arterial wall thickening when
traditional risk factors for CVD were controlled. Another
contradictory study [113] revealed no significant differ-
ence in CIMT between patients with primary SS and con-
trol patients. Additionally, a recent study found that
euthyroid premenopausal women with autoimmune thy-
roiditis [114] and allergic predisposition in early childhood
[115] might present significantly increased CIMT. Hence,
rheumatoid immunological diseases were related to CIM
thickening, and future prospective studies should account
for the roles and mechanisms of the above diseases in the
progression of atherosclerosis, and standard control and
treatment of these diseases so that subclinical atheroscler-
osis can be prevented as soon as possible.
The associations among CIMT and inflammatory
cytokines, lipid peroxidation, anthropometric hemocyte
parameters and infectious diseases
Inflammation and lipid peroxidation may play important
roles in the development of atherosclerosis. However,
whether immunological parameters, inflammatory cyto-
kines, and lipid peroxidation influence CIMT remains
unknown. Inflammatory cytokines such as CRP [43, 116]
and lipid peroxidation levels [117] correlated with in-
creases in CIMT. However, another study showed that
the distributions of MnSOD, GSTM1 and GSTP1 geno-
types according to CIMT, plaque type or plaque score
did not significantly differ [118]. The findings of our re-
cent study indicated that the increase in CIMT was not
associated with cytokine profiles, oxidative balance or
immune responses in patients with ALD [76]. Further
research is needed to explore the potential associations
between CIMT and inflammation and lipid peroxidation.
Leukocyte count and the neutrophil-to-lymphocyte ratio
may be used as diagnostic and prognostic indicators of
carotid atherosclerosis. Recent studies on anthropometric
hemocyte parameters revealed that leukocytes play an
independent role in early arterial damage and that these
cells may reflect subclinical disease [119]. The neutrophil-
to-lymphocyte ratio positively and moderately correlated
with CIMT in an entire study population [120]. Because
the above parameters are convenient and practical, they
may be used to evaluate the possibility of infection-related
CIM thickening.
The associations between CIMT and certain infectious
diseases have been a focus of clinical studies. A prelim-
inary study demonstrated that treated HIV infection is a
risk factor for subclinical atherosclerosis in older indi-
viduals [42]. However, in a predominantly female HIV-
infected population in South Africa [121], CIMT values
were considerably high and were associated with CV risk
factors rather than HIV-related factors. Another study
supports this viewpoint: old age, longer protease inhibi-
tor exposure, and impaired fasting glucose were inde-
pendent factors associated with common CIMT in a
population living with HIV [122]. Our previous study
[123] indicated that either H. pylori infection with
chronic alcohol use or chronic alcohol use alone could
cause a significant increase in CIMT. Additionally, tooth
loss and long-term periodontitis were related to subclin-
ical atherosclerosis in men but not in women [124].
Because only a few studies have examined the associ-
ation of inflammatory cytokines, lipid peroxidation,
anthropometric hemocyte parameters and infectious dis-
eases with CIMT, these parameters should be a focus of
further studies with larger samples for verification of
these findings.
The associations among CIMT and socioeconomic
position (SEP) and job stress
Few studies have shown that CIMT, SEP, and job stress
are associated. However, these studies lack consistent
conclusions. Present studies have revealed that job strain
was related to increased CIMT in valine (Val)/Val car-
riers [125], adulthood [126] and its early nonsympto-
matic stages in men [127]. Job strain appears to increase
the risk of preclinical atherosclerosis. A catechol-O-
methyltransferase genotype [125], a lack of leadership (a
type A behavior component) [126], and an increase in
hyperintense spots may explain the link between job
strain and cerebrovascular disease [128]. Additionally,
CIMT was associated with adult SEP [129] and shift
work [130]. However, high-strain jobs and low job con-
trol were not associated with IMT independent of SEP;
job stress did not explain the association between life
course SEP and CIMT [129]. High job demands, inter-
acting synergistically with low decision latitude, did not
result in the development of carotid atherosclerosis in
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men or in women [131]. The mechanisms of these asso-
ciations are unclear. Thus, we should strengthen the
studies on associations between CIMT and SEP and job
stress to take appropriate measures for early prevention
and treatment of atherosclerosis.
The associations between CIMT and vitamin D
Little is known regarding the association between vita-
min D and CIMT. The studies regarding an association
between serum vitamin D and CVD risk have presented
inconsistent results. Recently, several studies have shown
that low serum 25-hydroxyvitamin D3 (25(OH)D) levels
in childhood were associated with increased CIMT in
adulthood [132] and that subjects with serum 25(OH)D
â‰¥20Â ng/mL had less mean-max CIMT progression
following 3Â years of atorvastatin treatment, suggesting
that underlying vitamin D deficiency may be involved in
the response to atorvastatin in atherosclerosis preven-
tion [133]. Hence, early application of 25(OH)D or
coupling with oral lipid-lowering drugs such as statins
may be helpful for preventing subclinical atherosclerosis.
In contrast, serum levels of 25(OH)D were not inde-
pendently associated with CVD risk factors [134] or
CIMT [123, 135, 136]. However, increased serum
25(OH)D may predict subclinical atherosclerosis in non-
smokers [137]. Hence, the majority of the present stud-
ies do not support a protective effect of vitamin D
against subclinical atherosclerosis. More studies are
needed to explore whether 25(OH)D may affect the pro-
gression of atherosclerosis and the roles of 25(OH)D
supplementation on the atherosclerotic process.
The associations between CIMT and matrix
metalloproteinases (MMPs)
Evidence suggests that MMPs may play an important
role in atherosclerosis and be promising new therapeutic
targets for treating subclinical atherosclerosis. Higher
serum MMP-8 [37], MMP-9 [138, 139], TIMP-1 [138],
MMP-9/TIMP-1 [138] and MMP-10 [140] levels were
associated with increased CIMT. Hence, the above cir-
culating MMP levels may be useful for identifying sub-
clinical atherosclerosis. In summary, the roles of MMPs
in atherosclerosis should be further examined in clinical
studies for possible clinical application.
The associations between CIMT and other novel factors
and diseases
Recent studies have found that other novel factors and
diseases such as hepatorenal function, microalbumi-
nuria, low muscular strength, O3, beta-thalassemia
minor, growth hormone deficiency and normal-tension
glaucoma have certain relations to CIMT. Several stud-
ies have revealed that increased serum ALT levels (even
high-normal levels) were associated with markers of
CVD [51]. However, a study with opposing results re-
ported that age-adjusted CIMT values did not differ ac-
cording to GGT levels in males or females [53].
Microalbuminuria correlated with CIMT [141, 142], and
muscular strength was inversely and independently asso-
ciated with CIMT [92]. Childhood exposure to O3 may
be a novel risk factor for CIMT in a healthy population
of college students [143]. Additionally, higher CIMT was
associated with the development of chronic kidney dis-
ease [144], growth hormone deficiency [145], beta-
thalassemia minor [146], preeclampsia [142] and meno-
pause transition [147]. However, recent studies could
not show associations of elevated parathyroid hormone
(PTH) concentrations [136] and normal-tension glau-
coma [48] with altered CIMT. Therefore, the associa-
tions between CIMT and the above causes require
further verification.
Conclusions
This review of the recent literature presents preliminary
evidence of certain associations between CIMT and trad-
itional and novel CV risk factors, showing that CIMT is
a good clinical predictor of early atherosclerosis, and
that CIMT measurement is convenient, simple and prac-
tical. However, the majority of studies to date were
retrospective, and the lack of prospective large-scale
studies and of a unified measurement method used by
clinical researchers limited our analysis. Determining
which CIMT value (maximum CIMT, mean CIMT, mini-
mum CIMT, left or right common carotid artery) is
obviously associated with early atherosclerosis is neces-
sary. These findings remind us that early prevention of
atherosclerosis should start from infancy to enable
detection of an abnormal state of health. Further studies
focusing on both traditional and novel CV risk factors
are needed. Because the human body is a unified whole,
all types of abnormal states of health are likely to cause
harm to the human body, including the blood vessel sys-
tem. Hence, we should pay more attention to the health
status of the human body, and to protect blood vessels
and prevent early atherosclerosis, we should strengthen
the treatment of abnormal states of health and diseases.
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